FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Bioactive topics
Polypeptide
Aqueous Solution
Distributed
Therapeutics
Steoporosis
Intravenous
Osteoporosis
Side Effects
Computer Program
Biopolymer
Sacroiliac Joint
Immobilization
Condensation
Antimicrobial Resistance
Aluminum Phosphate

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Bioactive patents



      
           
This page is updated frequently with new Bioactive-related patent applications. Subscribe to the Bioactive RSS feed to automatically get the update: related Bioactive RSS feeds. RSS updates for this page: Bioactive RSS RSS


Delivery systems containing bioactive materials

Date/App# patent app List of recent Bioactive-related patents
07/17/14
20140200678
 Biomaterials with microsphere gradients and core and shell microspheres patent thumbnailBiomaterials with microsphere gradients and core and shell microspheres
Methods can prepare tissue engineering scaffolds that include a plurality of biocompatible core/shell microspheres linked together to form a three-dimensional matrix. The matrix can include a plurality of pores for growing cells.
07/17/14
20140200676
 Delivery systems containing bioactive materials patent thumbnailDelivery systems containing bioactive materials
A delivery system comprising a covering containing at least a first substance for release to a surgical site is provided. The covering includes an elongated containment portion having at least one compartment, wherein the covering includes an elongated containment having a first end and a second end.
07/17/14
20140199712
 Compositions and methods for capture of cellular targets of bioactive agents patent thumbnailCompositions and methods for capture of cellular targets of bioactive agents
The present invention provides compositions and methods for capture and identification of the cellular targets of a bioactive agent. In particular, provided herein are bioactive agents tethered to capture ligand, cellular targets (optionally tagged with a reporter), capture proteins (optionally present as capture fusions), surfaces (e.g., displaying, capture ligands, capture proteins, or capture fusions), and methods of capturing and identifying the cellular targets of a bioactive agent therewith..
07/17/14
20140199360
 Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development patent thumbnailControlled covalent attachment of bioactive bacteriophage for regulating biofilm development
Medical devices that are resistant to biofilm development and methods of the manufacture of biofilm resistant medical devices are provided. One or more bacteriophages are tethered to the surface of a medical device or a hydrogen-type coating on the surface of the device by covalent bonding while maintaining bacteriophage infective or lytic activity.
07/17/14
20140199269
 Chromobacterium bioactive compositions and metabolites patent thumbnailChromobacterium bioactive compositions and metabolites
Provided are bioactive compounds and metabolites derived from chromobacterium species culture responsible for controlling pests, compositions containing these compounds, methods for obtaining these compounds and methods of using these compounds and compositions for controlling pests.. .
07/17/14
20140196631
 Visual assays for coatings incorporating bioactive enzymes for catalytic functions patent thumbnailVisual assays for coatings incorporating bioactive enzymes for catalytic functions
Disclosed herein are materials such as a coating, comprising a lipolytic enzyme or organophosphrous compound degrading enzyme. Also disclosed herein are methods of visually detecting enzyme activity in a coating by contacting the coating with a substrate of an enzyme and a visual indicator that changes appearance upon production of a product of enzyme activity on a tack-free coating surface..
07/10/14
20140194701
 Gateway platform for biological monitoring and delivery of therapeutic compounds patent thumbnailGateway platform for biological monitoring and delivery of therapeutic compounds
The invention relates to methods and devices for remote or distributed continuous monitoring of physiologically relevant states. The invention provides for methods to automatically detect deviations or other states in physiological parameters and automatically alert a measured subject, user or other authorized party.
07/10/14
20140194604
 Process for the synthesis of ketones from internal alkenes patent thumbnailProcess for the synthesis of ketones from internal alkenes
The present invention is directed to methods for oxidizing internal olefins to ketones. In various embodiments, each method comprising contacting an organic substrate, having an initial internal olefin, with a mixture of (a) a biscationic palladium salt; and (b) an oxidizing agent; dissolved or dispersed in a solvent system to form a reaction mixture, said solvent system comprising at least one c2-6 carbon nitrile and optionally at least one secondary alkyl amide, said method conducted under conditions sufficient to convert at least 50 mol % of the initial internal olefin to a ketone, said ketone positioned on a carbon of the initial internal olefin.
07/10/14
20140194325
 Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer patent thumbnailRecognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
The present invention provides compositions and methods for detection and analysis of intracellular binding of a bioactive agent to a cellular target. In particular, provided herein are bioactive agents tethered to fluorophores, cellular targets fused to bioluminescent reporters, and methods of detecting and analyzing the interaction of bioactive agents with cellular targets therewith..
07/10/14
20140194307
 Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer patent thumbnailRecognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
The present invention provides compositions and methods for detection and analysis of intracellular binding of a bioactive agent to a cellular target. In particular, provided herein are bioactive agents tethered to fluorophores, cellular targets fused to bioluminescent reporters, or portions, components, or subunits of bioluminescent reporters, and methods of detecting and analyzing the interaction of bioactive agents with cellular targets therewith..
07/10/14
20140193499
Bioactive glass composition, its applications and respective preparation methods
The present invention relates to development of bioactive glass/glass-ceramic composition that are able to promote a fast deposition layer of carbonated hydroxyapatite upon immersion in simulated body fluid (sbf) for time periods as short as one hour. Such composition might include fluorides, and a variety of oxides (or their precursor compounds), such as na2o—ag2o—sro—cao—mgo—zno—p2o5—sio2—bi2o3—b2o3—caf2, be prepared by the melt route or by the sol-gel process, with the specific composition and the preparation route selected according to the intended functionalities, which can present controlled biodegradation rate and bactericidal activity.
07/10/14
20140193468
Methods for preparation of neo-cartilage constructs
The invention generally relates to systems (i.e. Constructs) for repairing cartilage and methods for preparing the same that introduce a bioactive agent into a culture medium, suspension, scaffold, solution incorporated into the pores of the scaffold, or combinations thereof.
07/10/14
20140193347
Lipid depot formulations
Wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents.
07/10/14
20140193335
Devices and methods for the treatment of cancer
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer..
07/03/14
20140188250
Modifiable medical grafts and related methods and apparatuses
Described are medical graft materials and devices which can be usefully modified with liquid additives such as cell suspensions, bioactive agents, or combinations of these. Also described are methods for making and using these medical graft materials and devices..
07/03/14
20140187614
Amino lipids, their synthesis and uses thereof
The present invention provides new amino lipids and a convenient method for synthesising these compounds. These (cationic) amino lipids have good properties as transfection agents.
07/03/14
20140187487
Affinity-based controlled release system
Prolonged or extended release of bioactive protein is achieved using an affinity-based approach which exploits the specific binding of src homology 3 (sh3) domain with short proline-rich peptides. Specifically, methylcellulose was modified with sh3-binding peptides (mc-peptide) with either a weak affinity or strong affinity for sh3.
07/03/14
20140187486
Peripheral administration of proteins including tgf-beta superfamily members for treatment of systemic disorders and disease
The present invention is directed to methods and compositions for accomplishing systemic delivery of minimally-soluble bioactive agents such as, but not limited to, proteins of the tgf-β superfamily via a peripheral mode of administration. According to the invention, an exemplary bioactive agent is bmp-7.
07/03/14
20140187473
Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-beta superfamily members
The present invention is directed to methods and compositions for systemic delivery of minimally-soluble bioactive agents such as, but not limited to, proteins of the tgf-β superfamily. According to the invention, an exemplary bioactive agent is bmp-7.
07/03/14
20140186952
Scaffold-free tissue constructs
A tissue construct comprising includes a self-assembled, scaffold-free, high-density cell aggregate. The cell aggregate includes a plurality of cells and a plurality of biocompatible and degradable nanoparticles and/or microparticles that are incorporated within the cell aggregate.
07/03/14
20140186456
Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement
The inventive tripartite composition is a combination of fucoidan, trans-resveratrol, and bovine colostrum in effective quantities, in the range of from 1:1.5:1.5 to 1:10:10 in weight percent. This composition provides antioxidant protection of cells against free radicals, strengthens the immune system, and enhances cellular function and stem cell population, thereby providing renewal and repair throughout the body.
07/03/14
20140186429
Recombinant protein, pharmaceutical composition containing the same, and method of biosynthesizing
The present invention provides a method of biosynthesizing a recombinant protein containing the biologically active peptide, the pharmaceutical composition containing the recombinant protein as well as the preparation of the recombinant protein. Simply speaking the consecutively multiple copies of the bioactive peptide are replaced in the amino acid sequence of a recombinant protein (so called peptide-protein).
07/03/14
20140186339
Compositions and methods for treating ocular diseases and conditions
The present invention relates to compositions and methods for prevention and treatment of ocular diseases and conditions, particularly glaucoma and ocular hypertension. The compositions and methods of the invention utilize immune-derived moieties that are specifically reactive against the bioactive lipid, sphingosine-1-phosphate, and its variants, which moieties are capable of decreasing the effective concentration of bioactive lipid being targeted.
07/03/14
20140186322
Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest
Disclosed is an adjuvant for improving the bioavailability of bioactive compositions. The adjuvant is prepared from a byproduct of mint flavor production.
07/03/14
20140186279
Topical bioadhesive formulations
Wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament..
07/03/14
20140183090
Bioactive packaging
Provided herein are packaging materials that include a bioactive material, as well as methods of using and methods of making such bioactive packaging material.. .
06/26/14
20140180434
Dynamic bioactive nanofiber scaffolding
A resorbable bone graft scaffold material, including a plurality of overlapping and interlocking fibers defining a scaffold structure, plurality of pores distributed throughout the scaffold, and a plurality of glass microspheres distributed throughout the pores. The fibers are characterized by fiber diameters ranging from about 5 nanometers to about 100 micrometers, and the fibers are a bioactive, resorbable material.
06/26/14
20140180399
Mesh enclosed tissue constructs
Described is a heart valve leaflet manufactured from a mesh material. The mesh material may have an ability to capture circulatory/stationary/migratory cells of the body to become biologically active.
06/26/14
20140180398
Bioabsorbable medical devices and methods of use thereof
One aspect provides implantable medical devices including a bioabsorbable structure having a surface and having a coating layer on at least a portion of the surface. In certain embodiments, the coating layer includes a releasable bioactive and provides for a controlled absorption of the bioabsorbable structure upon implantation in a human or veterinary patient.
06/26/14
20140180395
Bioactive spiral coil coating
An endovascular spiral coil coating and methods of making and using the same.. .
06/26/14
20140180330
Multi-lumen central access vena cava filter apparatus and method of using same
A combined multi-lumen central access catheter and an embolic filter including ports proximal and distal the filter for fluid infusion and/or pressure sensing and infusion ports in the catheter to permit infusion of bioactive agents, flushing agents and/or contrast agents. The embolic filter may be removably coupled to the multi-lumen catheter for temporary placement and retrieval under recommended indications..
06/26/14
20140179941
Synthesis and surface functionalization of particles
Provided are methods of controlling the shape and surface chemistry of nanoparticles, particularly ferrite nanoparticles. Methods for preparing non-spherical ferrite nanoparticles, including nanocubes, nanobars, nanoplates, and nanoflowers, are described.
06/26/14
20140179902
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
Complexes of heterocyclic radionuclides are prepared based upon ligands having substituted pyridyl and imidazolyl groups. The ligands are bifunctional, having amino acid residues that may act as a linker to a bioactive molecule, and a tridentate chelator that may complex the radionuclide.
06/26/14
20140179708
Multifunctional bioactive compounds
The invention relates to novel multifunctional bioactive compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds, in particular as therapeutic agents.. .
06/26/14
20140178563
Coated medical device
A coated medical device (10) including a structure (12) adapted for introduction into a passage or vessel of a patient. The structure is formed of preferably a non-porous base material (14) having a bioactive material layer (18) disposed thereon.
06/26/14
20140178453
Devices and methods for the regeneration of bony defects
This invention relates to methods for producing a composite bone graft material that can regenerate bony defects in the body. The invention further relates to methods that allow for the production of bioactive glass particles used in the composite that have been surface treated to allow for the production of a highly porous composite that can hold significant amounts of body fluid or other molecules that will aid in the regenerative process.
06/26/14
20140175330
Delivery methods and composition relating to bioactice polyelectrolyte acids from humified organic materials
Improved methods for the separation and isolation of bioactive polyelectrolytes, such as humic acid, fulvic acid, ulmic acid, and humin, from any one or a combination of naturally occurring or synthetically produced humified organic matter (hom) are described. The methods involve the application of an electromagnetic field to an aqueous slurry of the hom to thereby separate one or more bioactive polyelectrolyte fractions from the remaining of the hom.
06/19/14
20140172118
Bioactive compositions, bioactive eluting devices and methods of use thereof
One aspect provides a composition including triacetin, dimethyl sulfoxide and a bioactive. In one embodiment, the composition also includes a pharmaceutically acceptable carrier.
06/19/14
20140171619
Peptide-crosslinked bioactive polymeric materials
A method for creating a peptide crosslinked bioactive polymeric material includes reacting a hydroxy-functionalized small molecule with a amino acid to form an amino acid functionalized monomer, reacting the amino acid functionalized monomer with a urea bond former to form a amino acid-based poly(ester urea), and reacting the amino acid-based poly(ester urea) with a peptide based crosslinker to form the peptide crosslinked bioactive polymeric material.. .
06/19/14
20140170204
Multilayer thin film drug delivery device and methods of making and using the same
Multilayer thin film devices that include a bioactive agent for elution to the surrounding tissue upon administration to a subject are provided. The multilayer thin film devices are useful as medical devices, such as ocular devices.
06/19/14
20140166028
Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit
A method for the administration of nicotine, thc, tobacco, cannabidiol or a base alkaloid includes administering in the oral or nasal cavity an absorption conditioning unit having at least two agents selected from the group consisting of (a) a buffer agent, (b) a capturing agent, (c) a penetration agent, and (d) a thermal agent, to the mammal, and then administering by inhalation a bioactive agent selected from the group consisting of nicotine, thc, cannabidiol and a base alkaloid. The absorption conditioning unit may be in a dosage form not containing a drug.
06/19/14
20140166027
Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor producing device through use of an absorption conditioning unit
A method for the administration of nicotine, thc, tobacco, cannabidiol or a base alkaloid includes administering an absorption conditioning unit having at least two agents selected from the group consisting of (a) a buffer agent, (b) a capturing agent, (c) a penetration agent, and (d) a thermal agent, to the mammal, and then administering by inhalation a bioactive agent selected from the group consisting of nicotine, thc, cannabidiol and a base alkaloid. The absorption conditioning unit may be in a dosage form not containing a drug.
06/12/14
20140161874
Process of preparation and uses of plasma membrane vesicles extracted from plants enriched in membrane transport proteins
The invention relates to a method for obtaining membrane vesicles enriched in membrane transport proteins of plant origin, for cosmetic or therapeutic use, which can contain other substances, such as natural bioactive compounds. Preferably, said vesicles are obtained from plants of the brassicaceae (cruciferae) family.
06/05/14
20140155824
Drug delivery medical devices
Medical devices for delivering a bioactive agent and methods of use thereof are provided. The device includes a balloon having micro-needles for delivery of the bioactive agent..
06/05/14
20140154393
Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
The invention is generally directed to conjugated linoleic acid (cla)-rich vegetable oil production from linoleic rich oils by heterogeneous catalysis. A heterogeneous catalytic vacuum distillation process is used under high temperature conditions to isomerize linoleic acid in triacylglyceride vegetable oils to cla to produce cla-rich oils.
06/05/14
20140154371
Pulsed electric field treatment process and dairy product comprising bioactive molecules obtainable by the process
The present invention addresses the problem of inactivation of bioactive components in milk during pasteurization for preservation. The invention discloses a method of pulsed electric field (pef) treatment of whole milk, skimmed milk, semi-skimmed milk or whey, or other liquid compositions comprising milk components or fractions.
06/05/14
20140154217
Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom
New lactococcus lactis strains, nrrl b-50571 and nrrl b-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower ldl-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation..
06/05/14
20140154212
Crosslinked gelatin hydrogels
Hydrogels based on gelatin crosslinked with n,n′-methylenebisacrylamide (mba) are disclosed. The hydrogels according to the invention are useful for cell culture, growth and proliferation, for the controlled release of bioactive molecules, and to promote tissue regeneration..
05/29/14
20140148782
Tissue infusion system and method
An apparatus and corresponding method for providing convection enhanced delivery of bioactive agent to a tissue site. The apparatus involves the use of semipermeable membranes, typically in the form of one or more hollow fibers, together with a source and conduit of solution containing the bioactive agent to be delivered.
05/29/14
20140147488
Feed or food product composition
The present invention relates to a feed or food product composition which comprises a mixture of bovine colostrum, comprising bioactive components, and organic particulate matter having a size between 0.3 and 7 mm in diameter. The composition is especially adapted to deliver the mixture of bioactive bovine colostrum components to the digestive tract of a mammal..
05/29/14
20140147485
Polymer for creating hemocompatible surface
A polymer comprising a phosphoryl choline moiety(ies), a composition comprising the polymer and optionally a bioactive agent, an implantable device such as a des or a non-implantable device such as an angioplasty balloon comprising thereon a coating comprising the polymer and optionally a bioactive agent, and a method of using the device for the treatment of a disorder in a human being are provided.. .
05/29/14
20140147426
Anticaries compositions and probiotics/prebiotics
The present invention discloses different specific bacterial strains isolated from individuals without caries which are characterised in that they present inhibitory activity against cariogenic organisms. The invention also discloses a process for isolating said strains, as well as bioactive peptides, such as anti-microbial peptides of human and bacterial origin, which also show anti-cariogenic activity.
05/22/14
20140142039
Vasoactive lntestinal peptide release from microparticles
Controlled release of vip from plga microparticles was accomplished and varied through use of different polymer molecular sizes, addition of solutes to the inner aqueous phase, and use of our computer model. Released vip from microparticles appeared to be bioactive and caused dcs to produce more ccl22 than dcs treated with blank particles at 7 and 24 hours.
05/22/14
20140141978
Water miscible microemulsions of water insoluble film forming polymers
A water miscible emulsion composition which is essentially free of long-chain alkylpyrrolidone and aromatic oil comprising: (i) a long chain substituted amide; (ii) a water insoluble film forming polymer; (iii) a water soluble anionic surfactant; and (iv) optionally, a bioactive, is particularly useful in providing water repellency and delaying the onset of fungi growth on crops and leaves.. .
05/22/14
20140141490
Method facilitating removal of bioorganic stains from surfaces
Protein-polymer composite materials are provided according to embodiments of the present invention that include an admixture of a polymer resin, a surfactant and a non-aqueous organic solvent. An aqueous solution containing bioactive proteins is mixed with the admixture.
05/22/14
20140140974
Solubilized coq-10
The present invention is directed to compositions and methods of delivery of coq-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive coq-10 in formulations, such as soft gel capsules..
05/15/14
20140134701
Bacteriorhodopsin-containing bioactive gel and method for fabricating the same
The present invention discloses a bacteriorhodopsin-containing bioactive gel and a method for fabricating the same, wherein a thickening polymeric compound is suspended in water to form a base gel having appropriate glutinosity and suitable for skin, and wherein a bacteriorhodopsin-containing culture fluid, which is obtained via culturing halobacteria in a spent culture fluid, is integrated with the glutinous base gel to form the bacteriorhodopsin-containing bioactive gel. The bioactive gel of the present invention is abundant of vitamins, minerals, amino acids, etc.
05/08/14
20140128256
Bacillus sp. strain with antifungal, antibacterial and growth promotion activity
Disclosed herein is a bacillus strain, bacillus sp. Isolate f727, that produces metabolites with pesticidal activities.
05/01/14
20140121707
Methods for delivery of screws for joint fusion
Procedures for the fusion of the sacroiliac joint advantageously make use of an implant selected to distract the joint upon insertion and to maintain or increase tension upon insertion. The implant can have a varying structure along its length.
04/24/14
20140114228
Methods and devices to curb appetite and/or to reduce food intake
The present invention relates to devices and methods of operating the devices that contribute to curbing appetite and/or reducing food intake. In some embodiments, the methods and devices of the present invention include as intestinal/duodenal insert comprising an elongated member with at least one flow reduction element that can cause the stimulation of one or more biological signals of satiety.
04/24/14
20140112921
Increased bioavailability of transdermally delivered agents
A method for delivering a bioactive agent to the cardiovascular system is described. The method delivers the agent at a high bioavailability and with little loss of agent to the natural defense mechanisms of the body.
04/24/14
20140112900
Solubilized coq-10
The present invention is directed to compositions and methods of delivery of coq-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive coq-10 in formulations, such as soft gel capsules..
04/17/14
20140106341
Stabilized bioactive peptides and methods of identification, synthesis, and use
An intracellular selection system allows screening for peptide bioactivity and stability. Randomized recombinant peptides are screened for bioactivity in a tightly regulated expression system, preferably derived from the wild-type lac operon.
04/17/14
20140106035
Health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil, and method for obtaining the same
The subject of invention is the health-giving foodstuff containing ethyl esters of fatty acids of linen oil or linen oil and fish oil, characterised in that it constitutes of microcapsules in form of powder, which contains, in a protein-carbohydrate matrix, a nutraceutical with bioactive ethyl esters of acids ala, la or ala, la, dha, epa with not more than 4 percent by weight addition of ethanol, based on at least 99.8% anhydrous pharmaceutical ethanol, in form of drops of diameter less than 21.1m. The nature of the invention is also a method for obtaining of the health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil or linen oil and fish oil, by mixing of ingredients, their homogenisation, drying, characterised by that after obtaining liquid protein-carbohydrate matrix, a nutraceutical containing bioactive ethyl esters of acids ala, la or ala, la, dha, epa is introduced into it, followed by carrying out of dispergation of ester phase by mechanical agitation until stable form of emulsion is obtained, which is then treated with two-steps and two-stages pressure homogenisation: in 1st stage—at pressure of at least 20 mpa on the 1st step and 4 mpa at the 2nd step, and in 2nd stage—at pressure of at least 30 mpa on the 1st step and 10 mpa at the 2nd step, whilst homogenisation during the 1st stage is carried out in process coupled with thermal processing of the emulsion, which is then spray dried in atmosphere of temperature 160-190° c.
04/17/14
20140105875
Nutritional compositions having exogenous milk fat globule membrane components
Nutritional compositions including milk fat globule membrane components (“mfgm”) and at least one nutrient are provided. The milk-derived, bioactive lipids help to modulate conditions typically found in the elderly including, for example, low-grade inflammation, loss of lean body mass, skeletal muscle cell membrane instability, and joint inflammation.
04/17/14
20140105849
Bioactive aniline copolymers
Aniline copolymers and the synthesis thereof for use as antimicrobial (antibacterial, antifungal or antiviral material) material for the manufacture of antimicrobial objects, suitable for use in the health, food, packaging, water, paint, wood, textile, poultry, glass, paper, rubber, ceramic, seafood, sports, plastic and agricultural industries. The copolymer may be for example (a): where for example r3=h5—co2h, —co2me, or co2et, r is typically h or a c1-c6 alkyl, x is an integer between 1 and 0 and m indicates the degree of polymerization.
04/10/14
20140099389
Topical anti-inflammatory combination
Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of sambucus nigra, centella asiatica or echinacea purpurea, and an effective amount of a quaternary ammonium surfactant.. .
04/10/14
20140099370
Controlled release of biologically active compounds
The present invention relates to biodegradable polymers (e.g., polyesters and polyester amides) derived from functionalized biologically active compounds that can provide site specific delivery of bioactive compounds upon biodegradation in a controlled manner.. .


Popular terms: [SEARCH]

Bioactive topics: Polypeptide, Aqueous Solution, Distributed, Therapeutics, Steoporosis, Intravenous, Osteoporosis, Side Effects, Computer Program, Biopolymer, Sacroiliac Joint, Immobilization, Condensation, Antimicrobial Resistance, Aluminum Phosphate

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Bioactive for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bioactive with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4711

3269

449495 - 0 - 72